Designing safer analgesics via μ-opioid receptor pathways
Pain is both a major clinical and economic problem, affecting more people than diabetes,
heart disease, and cancer combined. While a variety of prescribed or over-the-counter …
heart disease, and cancer combined. While a variety of prescribed or over-the-counter …
Bifunctional opioid receptor ligands as novel analgesics
CW Cunningham, WM Elballa, SU Vold - Neuropharmacology, 2019 - Elsevier
Prolonged treatment of chronic severe pain with opioid analgesics is frought with
problematic adverse effects including tolerance, dependence, and life-threatening …
problematic adverse effects including tolerance, dependence, and life-threatening …
Targeting multiple opioid receptors–improved analgesics with reduced side effects?
T Günther, P Dasgupta, A Mann, E Miess… - British journal of …, 2018 - Wiley Online Library
Classical opioid analgesics, including morphine, mediate all of their desired and undesired
effects by specific activation of the μ‐opioid receptor (μ receptor). The use of morphine for …
effects by specific activation of the μ‐opioid receptor (μ receptor). The use of morphine for …
Biased ligands at opioid receptors: Current status and future directions
The opioid crisis represents a major worldwide public health crisis that has accelerated the
search for safer and more effective opioids. Over the past few years, the identification of …
search for safer and more effective opioids. Over the past few years, the identification of …
[HTML][HTML] Mu opioid receptor heterodimers emerge as novel therapeutic targets: recent progress and future perspective
L Zhang, JT Zhang, L Hang, T Liu - Frontiers in pharmacology, 2020 - frontiersin.org
Opioids are the most effective analgesics used in the clinical management of cancer pain or
non-cancer pain. However, chronic opioids therapy can cause many side effects including …
non-cancer pain. However, chronic opioids therapy can cause many side effects including …
Basic opioid pharmacology—an update
A James, J Williams - British journal of pain, 2020 - journals.sagepub.com
Opioids are a group of analgesic agents commonly used in clinical practice. The three
classical opioid receptors are MOP, DOP and KOP. The NOP (N/OFQ) receptor is …
classical opioid receptors are MOP, DOP and KOP. The NOP (N/OFQ) receptor is …
Strategies towards safer opioid analgesics—A review of old and upcoming targets
BR Varga, JM Streicher… - British journal of …, 2023 - Wiley Online Library
Opioids continue to be of use for the treatment of pain. Most clinically used analgesics target
the μ opioid receptor whose activation results in adverse effects like respiratory depression …
the μ opioid receptor whose activation results in adverse effects like respiratory depression …
Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics
ER Siuda, R Carr III, DH Rominger, JD Violin - Current opinion in …, 2017 - Elsevier
Highlights•Biased MOR ligands discovered using empirical, rational and natural product
approaches.•Biased MOR ligands produce analgesia with fewer side effects in mice and …
approaches.•Biased MOR ligands produce analgesia with fewer side effects in mice and …
Basic opioid pharmacology: an update
H Pathan, J Williams - British journal of pain, 2012 - journals.sagepub.com
Opioids are a group of analgesic agents commonly used in clinical practice. There are three
classical opioid receptors (DOP, KOP and MOP), while the novel NOP receptor is …
classical opioid receptors (DOP, KOP and MOP), while the novel NOP receptor is …